NCT00894335

Brief Summary

This study is a prospective, perioperative evaluation of hemodynamic and respiratory parameters in patients undergoing retroperitoneoscopic adrenalectomies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

May 6, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 7, 2009

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

June 28, 2011

Status Verified

May 1, 2009

Enrollment Period

3.8 years

First QC Date

May 6, 2009

Last Update Submit

June 27, 2011

Conditions

Adrenal Tumors

Keywords

retroperitoneoscopic adrenalectomyintraoperative arterial-alveolar Carbon dioxide Difference

Outcome Measures

Primary Outcomes (1)

  • Arterial-alveolar Carbon dioxide Difference

    3 years

Secondary Outcomes (1)

  • Perioperative maximal mean arterial pressure

    3 Years

Study Arms (5)

1

Pheochromocytoma

2

Conn-Syndrome

3

Cushing disease

4

Metastasis

5

Non-functional tumor

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with adrenal tumors scheduled for retroperitoneal adrenalectomies

You may qualify if:

  • Patients with an adrenal tumor

You may not qualify if:

  • Age below 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinics Essen-Mitte

Essen, 45136, Germany

RECRUITING

Related Publications (1)

  • Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery. 2006 Dec;140(6):943-8; discussion 948-50. doi: 10.1016/j.surg.2006.07.039.

    PMID: 17188142BACKGROUND

MeSH Terms

Conditions

Adrenal Gland Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsAdrenal Gland DiseasesEndocrine System Diseases

Study Officials

  • Harald Groeben, Prof, M.D.

    Clinics Essen-Mitte

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Harald Groeben, Prof., M.D.

CONTACT

##49 201 174h.groeben@kliniken-essen-mitte.de

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 6, 2009

First Posted

May 7, 2009

Study Start

May 1, 2008

Primary Completion

March 1, 2012

Study Completion

July 1, 2012

Last Updated

June 28, 2011

Record last verified: 2009-05

Locations

DE(1)